date,title,source
Oct-18-18,Verastem Oncology Announces Executive Leadership Appointments and Changes,Business Wire
Oct-18-18,"A Stock to be ""Aware of"" for Liver Cancer Awareness Month",ACCESSWIRE
Oct-24-18,"New Research Coverage Highlights Zoetis, TripAdvisor, The Gap, Unit, WestRock, and Verastem  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-30-18,What's in Store for Verastem (VSTM) This Earnings Season?,Zacks
Nov-01-18,Cannabis and Biotech Firms Making Investors Boatloads,ACCESSWIRE
Nov-01-18,Verastem Oncology Announces Data Presentations at the American Society of Hematology 2018 Annual Meeting,Business Wire
Nov-05-18,Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Business Wire
Nov-06-18,Verastem Oncology Announces Presentation of Preclinical Data Supporting Dual PI3K-delta and PI3K-gamma Inhibition in Combination with Immunotherapy at the Society for Immunotherapy of Cancers 33rd Annual Meeting,Business Wire
Nov-07-18,Verastem Oncology Reports Third Quarter 2018 Financial Results,Business Wire
Nov-07-18,Verastem Oncology Announces Collaboration with The Leukemia & Lymphoma Society to Accelerate Development of Duvelisib for the Treatment of Peripheral T-Cell Lymphoma,Business Wire
